Navigation Links
Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
Date:4/30/2013

SAN DIEGO, April 30, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced today the US market launch of its proprietary new test, PROMETHEUS® Anser™ ADA.  This novel test measures drug (adalimumab) and drug antibody levels in one serum sample in inflammatory bowel disease (IBD) patients using adalimumab (ADA) – helping physicians identify potential causes for loss of treatment response and thus help guide patient management decisions. PROMETHEUS Anser ADA, which utilizes Prometheus' proprietary homogenous mobility shift assay, follows the July 2012 introduction of PROMETHEUS Anser IFX to further expand the line of tests that target biologic agents being used to treat a variety of autoimmune diseases.

The Crohn's and Colitis Foundation of America estimates that approximately 1.4 million Americans suffer from IBD.  Many of these patients will use a biologic treatment like adalimumab to manage and control the symptoms of their disease.  Over time, however, these biologic agents may lose their effectiveness, resulting in increased disease activity and high discontinuation rates. This loss of treatment response is typically the result of: (1) insufficient drug levels, or (2) the development of antibodies to the biologic agent itself.

Recent clinical studies suggest that as many as 44 percent of IBD patients who have lost response to adalimumab have antibodies to the drug.1 If a patient loses treatment response to ADA, the most common first step for physicians is dose escalation, however depending on the mechanism of the loss of response, this may result in exposure of the patient to unneeded high drug doses and unnecessary expense.

"PROMETHEUS Anser ADA marks the latest milestone in our ongoing commitment to developing diagnostics to help guide personalized treatment decisions for gastroenterologists, patients
'/>"/>

SOURCE Prometheus Laboratories Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
2. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
3. UBM Medica US Launches Practice Management iPad App, Offering Efficient Business Solutions for Busy Physicians
4. NextDocs Launches QuickStart for Emerging Growth Companies
5. Neusoft Medical Launches New Products to Global Market at 2013 Spring CMEF
6. Healthcares First Direct Contracting Market Launches Today; Will Offer Mutually Beneficial Approach for Hospitals and Suppliers
7. Sanovas Launches Next Generation Surgical Imaging Technology
8. MR Solutions Launches Complete Range of Pre Clinical Helium Free MRI Scanners
9. CSOS Launches the Guangdong-Hong Kong "999" Emergency Assistance Membership Programme
10. AsthmaSense Cloud Launches With New Features To Better Monitor Asthma
11. Aribex Launches NOMAD Pro 2 in US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015 /OFF HOLD OFF ... PIV757417 The following release: "Biotech Advancements Coupled with ... & Treatments for Critical-Care Patients With Severe Wound ... Aug 2015 12:30 GMT Cooperative research ... research and top-tier universities for identifying biotech solutions ...
(Date:8/3/2015)... Fla. , Aug. 3, 2015  Charleston ... initiation of its second clinical development program with ... candidate, CL-H1T.  CL-H1T contains fast-dissolving ... being developed as a treatment for migraine headache ... "Many patients with migraine headaches also ...
(Date:8/3/2015)... Israel , August 3, 2015 ... it received the statistical analysis of results from a study ... the BVX-005 phase II trial which took place in 2012, ... not exist at the time of the study- in particular ... the epidemic in the United States ...
Breaking Medicine Technology:/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
(Date:8/3/2015)... ... 03, 2015 , ... Zeiter’s Septic now performs septic installations ... and operated business, Zeiter’s Septic has been serving the community for over 20 ... because of their continued training and perseverance to provide their customers with new ...
(Date:8/3/2015)... ... August 03, 2015 , ... Since 1978, the number ... according to a new publication released today by the AAMC (Association of American Medical ... graduates over the past three decades, the number of black male applicants to medical ...
(Date:8/3/2015)... ... ... an opinion piece published July 28 by the Washington Post, the conventional wisdom ... may not be accurate. While this system may work for some people, the author notes ... both on the individual and at what point that person is in their weight loss ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B Awards ... brands. BESLER Consulting's campaign for the launch of their Readmissions Analytics product was ...
(Date:8/3/2015)... ... August 03, 2015 , ... A recent ... overwhelming number of Hispanics believe people can positively affect their diabetes, few look ... queried said making diet changes was important. Far fewer participants mentioned the need ...
Breaking Medicine News(10 mins):Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 2Health News:Zeiter’s Septics Performs Affordable Septic Installations Throughout Livingston & Putnam Counties Effective Immediately 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 2Health News:New Publication Focuses on the Decline of Black Males in Medicine 3Health News:New Publication Focuses on the Decline of Black Males in Medicine 4Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4
... in spite of depression being common among long-term survivors of ... patients suffering from depression have been found to have reduced ... it is important to identify and treat depression after stroke," ... National Stroke Research Unit in Victoria, Australia, said in a ...
... statin medications reduces death and cardiovascular events for ... acute heart events//, according to an analysis. ... clearly been shown to benefit patients with cardiovascular ... However, it is less clear whether these drugs ...
... seven women will develop breast cancer in her life. But ... // ,Breast cancer specialists from the University of Michigan ... anxiety than necessary. And in some cases the fear paralyzes ... lead to successful treatment. ,Here, experts debunk some ...
... care in United Kingdom, and a munificent grant of ?45 ... figure anywhere on the NHS dental list. , ,The ... NHS registrations, down by a 42000 enrollments. This, notwithstanding the ... to ensure registrations are maintained. Yet, it has not made ...
... to Japanese encephalitis, the death toll since April this ... ,According to the Additional Director (Health) Umakant Prasad, 15 ... from several parts of the district since Wednesday evening. ... undergoing treatment at the BRD Medical College Hospital in ...
... the British Journal of Sports Medicine says that a ... of her fingers//. Researchers said that the finding could ... fertility, vulnerability to serious disease, intellectual ability, certain personality ... research in this area has so far focused exclusively ...
Cached Medicine News:Health News:Early Statin Therapy for Patients Reduces Death, Cardiovascular Events 2Health News:16 Common Myths About Breast Cancer 2Health News:16 Common Myths About Breast Cancer 3Health News:16 Common Myths About Breast Cancer 4Health News:16 Common Myths About Breast Cancer 5
... is a lateral-flow immuno-chromatographic assay intended for ... specific to Helicobacter pylori in human serum, ... convenient, non-invasive, and easy to perform test ... of H.pylori infection in patients with clinical ...
... HP is a visually read, qualitative immunochromatographic ... H. pylori, a bacterium that grows in ... ulcer disease and some gastric cancers. FlexSure ... blood or serum samples, provides the physician ...
... Infectious Mononucleosis test is designed to ... serum, plasma or whole blood. The ... extract of bovine erythrocytes which give ... similar extracts prepared from sheep and ...
... The QuickVue Influenza A+B test ... of influenza type A and type ... nasal wash and/or nasal aspirate specimens. ... aid in the rapid differential diagnosis ...
Medicine Products: